Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: T32 CA009172
NCI NIH HHS
Grant: P30 CA016359
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: P30 CA006516
NIDDK NIH HHS
Grant: T35 DK104689
NCI NIH HHS
Grant: R37 CA279822
NCI NIH HHS
Grant: P50 CA101942
MeSH Terms